{"name":"Mabylon AG","slug":"mabylon-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxONXREajc3Yk43S2tLTkE0a2tvZFIzYnZlbmM4SmJXNEQ1VHlhRFpzak9zdUFXUHlQaHBqQkNqNWJNUjByejNpYWpvUWVSZE56NmRFdGFqSlZOYUh5NEJlNm1zeDM3VUUyTXlJRURpSXdxYVhDZmlBbUpkaWllNkQ4M2pVUjdOTy1wbTFXekN4aTVwQkwwTXlMV0ozMUJyZWFJZUFDNkFHNTRYZ0tlM0NyM1IzcUxiQ1N4eE5VTnZ0Tm9tSEFUTU9aeVB4Z1hvYkxy?oc=5","date":"2026-01-06","type":"pipeline","source":"BioBuzz","summary":"Maryland-based SciNeuro Closes $53M Raise to Advance Neurodegenerative Pipeline and Appoints New CFO - BioBuzz","headline":"Maryland-based SciNeuro Closes $53M Raise to Advance Neurodegenerative Pipeline and Appoints New CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOWDdyODI1cU5GZlB6cGhnMlVoQnFZQVNEMGI3eXZfNzRZaXNxQ3daZGFZaU90emNPekVHaS1OZlFqc2kta1Zrb1QtbjZUTEdKR1dLdVhWZGhUZ2xSaDQzT1hqSEtqVmcwOGR3QnFWWUY0OE5xZFlBeDJNeFMyLUoyc2tCcmZXY3hvUXhDRmw4bFZWa0tqQmJBZjlLN2x3d2N5M2xkVVhNcXVYM1VSX1ZKUXU4MW91ZGxSZHAxVXhKY3ItQVRIQ0xkMXF0NFlPR3ZBdjRaMjBlUUtnOWp6SlJUZw?oc=5","date":"2025-03-10","type":"pipeline","source":"BioWorld News","summary":"Half-life extended trispecific anti-peanut antibody provides continuous protection from allergic reactions - BioWorld News","headline":"Half-life extended trispecific anti-peanut antibody provides continuous protection from allergic reactions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNSVFxR1RTQ1JnbFZhbTd3TjlFd09nejVLdjVlcFNvajliZHlTNm5DLUZTYk9vczNiQTBiNjdmOHNwT19VdmtQM1dfQkRLbjc2dUxNMGQtaHkwRVR4ZnNyaDhfTE1OS21nYTJhMlNYOVJXRDFpZjRyOW9aX1Z3bHA1bE12NDdaeUtBemc?oc=5","date":"2025-01-01","type":"pipeline","source":"Switzerland Global Enterprise (S-GE)","summary":"Mabylon further develops active substance to treat peanut allergy with Pfizer - Switzerland Global Enterprise (S-GE)","headline":"Mabylon further develops active substance to treat peanut allergy with Pfizer - Switzerland Global Enterprise (S-GE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNOXZuMElOS19nSFc0aDFnM3VRZ0g4X0Rfb2xRNWlLM3l6YTVlWlluN3ZFRXFSeG1tSDRONG1ncXJQSG5JejA3ZEs5ckxLNWE2Q0JCUVY5bE5hZFhNdGJwNHRxdGpsSDJQN19nY202Z0lLLXU4UDhVQ05PNVJTWnJwWFNRRDNQOXFxV2dOWVFqeGIxZVZDRENyQjRYM2F2Ri1qbXJIY3hHMUhNUQ?oc=5","date":"2024-09-30","type":"pipeline","source":"Startupticker.ch","summary":"Financial support sets Mabylon on track to advance allergy treatments - Startupticker.ch","headline":"Financial support sets Mabylon on track to advance allergy treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQTDhhVUl6QlN3bk5aQnEzWWotQmNzVm5ZWjlRVDRnZ2NOR2xGeEc2dkFCenFUNVl2aU5RS1htdHRMZzlrNkxKbXR4bGl0UlRYTDlwdzYxVzZmeWNJZF9GZlUyLVVfVHo5V0lZVXR4MVh2OHlwWjl3N1dvOU0tVUY3TXdFV254cGZVQjZXZGI1OWJ4emwyZ2JDNFlrM3IwRnRfZkpqVVZyWjNuSlFiLTdRMld1QTFVWjdwS1FmOXVQUEZyRTVJVFNxbGMwZ1A2Q0g2OTRMc1B4cUhkdm5X?oc=5","date":"2021-04-14","type":"pipeline","source":"Business Wire","summary":"SciNeuro Pharmaceuticals Announces Exclusive Licensing Agreement with Eli Lilly & Company - Business Wire","headline":"SciNeuro Pharmaceuticals Announces Exclusive Licensing Agreement with Eli Lilly & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPUkplV2pVOXNscG9KN3lsVE82Snl6eFVoS2RxdU1qUWcwYXNhM29LeUFXdlJRLUFjd2haTWI2Ylg3REtyQ3QycjV0dFVoOWNUczZsemxvZ0RraExWcDRYRTVZcmg2dWZnNXIza2hxWDV6eFc4UG9hd3FrM1lyVVhJWER1YzR5aGtTTjhkNENXMEVwakIxaTJQZF9LV1IzVjhrejNuU0M5UGkzUVlmQ0ZWMllhNUQ4bko4UUZkZ1Awbi04c0tNbkgtbVQ2aEJvYzdNN1hLYw?oc=5","date":"2020-12-08","type":"pipeline","source":"Business Wire","summary":"SciNeuro Pharmaceuticals Launches to Bring Innovative Treatments for CNS Diseases - Business Wire","headline":"SciNeuro Pharmaceuticals Launches to Bring Innovative Treatments for CNS Diseases","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}